NemaLife Inc.

That is why we are committed to empowering food producers to provide food of the highest quality and safety. We are an interdisciplinary team of experts supported by an experienced board of directors as well as renowned advisors. We are in the process of expanding to new markets and making our products available all over the world. We are always looking for innovative companies to further advance our technology and solutions in the field of diagnostics. We are convinced that with this test, we have found a reliable and user-friendly test method for our environmental monitoring program for Listeria monocytogenes. NEMIS Technologies AG was originally founded by Biosynth Carbosynth Ltd., Ramot and NEMIS’ senior management as a Swiss biotech start-up, based in Dubendorf, Switzerland. Distribution Partnerships established in Spain, Italy, Benelux, Netherlands and France. At NEMIS, we believe safe food is a human right.

We are a respected global company with laboratories and teams located in the United States, China, and other countries. Human imagination and innovation—coupled with new technology—are shaping an industry through innovative ways to treat aggressive diseases. N1 Life’s fearless pursuit of drug delivery technologies—using science as the solution—leads the way to overcome traditional drug development’s high failure rate because of human tissue complexities. With tissue as the issue, our new technologies are paving the way for life-changing treatment opportunities for people experiencing severe and untreatable diseases. N1 Life is a pioneering company in the field of drug delivery technology. Our new technology platforms, AbsotrideTM Peptide-based Delivery Platform, and ChARLSTM Polymer-based Delivery Platform enable better drug discovery and development. N1 Life is a biotech company that originated as a Stanford University spinout start-up to develop innovative tissue-focused drug delivery technologies for new therapeutics to address unmet medical needs. N1 Life was cofounded by Stanford professor Dr.

We are a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL), founded in Switzerland in 2019. We provide cutting-edge laboratory equipment for fully automated high-content screening of substances as a 3R alternative to animal testing. We develop innovative technologies that automate end-to-end screenings on small organisms so you can focus on what is important: your results. We are actively pursuing technologies to identify adverse toxicology as early as possible, including through the use of model systems such as those being investigated by Nagi Bioscience. This is the story of the microsystems expert Dr.

NEM is the leading Australian owned producer of scientifically developed biofertiliser, biostimulant and biocontrol products for agriculture. Founded – and grounded – in science, we’re working to ensure farmers can access the scientifically proven microbes that are fundamental to farm productivity, sustainability and soil and plant health. Over 20 years, our product offering has grown from an original focus on Rhizobium legume inoculants to a range of other biological products for plant growth improvement. Leveraging market leading research and commercial partnerships, and advanced product development pipeline, NEM is well-placed to capitalise on the rapidly growing demand for biological inputs for sustainable agriculture. NEM’s vision is built on delivering scientifically proven microbes that are fundamental to farm productivity, sustainability and plant and soil health. NEM is the leading Australian owned producer of biofertiliser and biostimulant products for agriculture.

Our mission is to accelerate the world’s transition to safer chemicals without vertebrate animal testing, by helping our customers to better understand the root causes of exposure-related harm and to report that knowledge to the chemical regulators. We are proud to promote the 3Rs (replacement, reduction and refinement of animal testing), and equally proud to promote safety-by-design. We founded Michabo Health Science in 2018 as a trading division within University of Birmingham Enterprise Limited. We provide services in chemical grouping, hazard prediction and benchmark dose modelling to determine the potencies of chemicals. We provide customised training in NAMs, including molecular biomarkers, omics technologies and machine learning/AI to ensure the regulators and the regulated can benefit from these innovative solutions. We are also co-developing international compliance standards for the application of NAMs to regulatory toxicology. We’ve earned an international reputation and built networks in chemical safety science with both the regulators and the regulated. We combine state-of-the-art NAM technologies with specialised data science to accelerate and increase certainty in chemical safety assessments.

Canomiks was founded by a team of world-leading academics and scientists with over 50 years of combined experience in bioinformatics, genomics, medicine, clinical science, and pharmacology. Canomiks was founded by three Harvard professors and renowned scientists with a mission to bring the most cutting edge science to the natural products industry. LoGerfo, they launched Canomiks to leverage their combined expertise in genomics, medicine, and pharmacology and apply it to the natural products industry. At Canomiks, we work with ingredient suppliers, finished product manufacturers, marketers, and retailers in the dietary supplement, functional food and beverage, and health and beauty industries to help them create safe and efficacious products. We are the first technology company that uses genomics and AI to validate, test and certify the biological efficacy and safety of botanical ingredients. Canomiks’ technology development is partly funded by the National Science Foundation (NSF). Canomiks exclusive intellectual property and groundbreaking technology are transforming the functional food and beverage and dietary supplement industry. Our vision is to ‘Make Food as Medicine a Reality®’ with the goal to help make our communities healthier and our planet more sustainable.